Merle B, Malaval L, Lawler J, Delmas P, Clezardin P
INSERM Research Unit 403, Hôpital Edouard Herriot, Lyon, France.
J Cell Biochem. 1997 Oct 1;67(1):75-83.
Skin decorin (DCN) is an antiadhesive dermatan sulfate-rich proteoglycan that interacts with thrombospondin-1 (TSP) and inhibits fibroblast adhesion to TSP [Winnemöller et al., 1992]. Molecular mechanisms by which DCN interacts with TSP and inhibits cell adhesion to TSP are unknown. In the present study, we showed that skin DCN and bone DCN (chondroitin sulfate-rich proteoglycan) were quantitatively identical with respect to their ability to interact with TSP. Using a series of fusion proteins corresponding to the different structural domains of TSP, binding of [125I]DCN to TSP was found to be dependent of the N-terminal domain and, to a lesser extent, of the type 1 repeats and the C-terminal domain of TSP. In addition, heparan sulfate drastically inhibited [125I]DCN binding to solid-phase adsorbed TSP (80% inhibition), suggesting that DCN could bind to the N-terminal domain of TSP through interaction with heparin-binding sequences. To address this question, a series of synthetic peptides, overlapping heparin-binding sequences ARKGSGRR (residues 22-29), KKTR (residues 80-83) and RLRIAKGGVNDN (residues 178-189), were synthesized and tested for their ability to interact with DCN. [125I]DCN interacted only with peptides VDAVRTEKGFLLLASLRQMKKTRGT and KKTRGTLLALERKDHS containing the heparin-binding consensus sequence KKTR. These peptides contained glycosaminoglycan-dependent and -independent binding sites because [125I]DCN binding to VDAVRTEKGFLLLASLRQMKKTRGT and KKTRGTLLALERKDHS was partially reduced upon removal of the glycosaminoglycan chain (65% and 46% inhibition, respectively). [125I]DCN poorly bound to subpeptide MKKTRG and did not bind at all to subpeptides VDAVRTEKGFLLLASLRQ and TLLALERKDHS, suggesting that heparin-binding sequence MKKTRG constituted a DCN binding site when flanked with peptides VDAVRTEKGFLLLASLRQ and TLLALERKDHS. The sequence VDAVRTEKGFLLLASLRQMKKTRGTLLALERKDHS constitutes a cell adhesive active site in the N-terminal domain of TSP [Clezardin et al., 1997], and DCN inhibited the attachment of fibroblastic and osteoblastic cells to peptides VDAVRTEKGFLLLASLRQMKKTRGT and KKTRGTLLALERKDHS by about 50 and 80%, respectively. Although fibroblastic cells also attached to type 3 repeats and the C-terminal domain of TSP, DCN only inhibited cell attachment to the C-terminal domain. Overall, these data indicate that modulation by steric exclusion of cell adhesion to a KKTR-dependent cell adhesive site present within the N-terminal domain of TSP could explain the antiadhesive properties of DCN.
皮肤核心蛋白聚糖(DCN)是一种富含硫酸皮肤素的抗黏附蛋白聚糖,它与血小板反应蛋白-1(TSP)相互作用,并抑制成纤维细胞与TSP的黏附[Winnemöller等人,1992年]。DCN与TSP相互作用并抑制细胞与TSP黏附的分子机制尚不清楚。在本研究中,我们发现皮肤DCN和骨DCN(富含硫酸软骨素的蛋白聚糖)在与TSP相互作用的能力方面在数量上是相同的。使用一系列与TSP不同结构域相对应的融合蛋白,发现[125I]DCN与TSP的结合依赖于TSP的N端结构域,在较小程度上还依赖于TSP的1型重复序列和C端结构域。此外,硫酸乙酰肝素显著抑制[125I]DCN与固相吸附的TSP的结合(80%抑制率),这表明DCN可能通过与肝素结合序列相互作用而与TSP的N端结构域结合。为了解决这个问题,合成了一系列重叠肝素结合序列ARKGSGRR(第22 - 29位氨基酸残基)、KKTR(第80 - 83位氨基酸残基)和RLRIAKGGVNDN(第178 - 189位氨基酸残基)的合成肽,并测试它们与DCN相互作用的能力。[125I]DCN仅与含有肝素结合共有序列KKTR的肽VDAVRTEKGFLLLASLRQMKKTRGT和KKTRGTLLALERKDHS相互作用。这些肽含有糖胺聚糖依赖性和非依赖性结合位点,因为去除糖胺聚糖链后,[125I]DCN与VDAVRTEKGFLLLASLRQMKKTRGT和KKTRGTLLALERKDHS的结合分别部分降低(分别为65%和46%抑制率)。[125I]DCN与亚肽MKKTRG结合较差,与亚肽VDAVRTEKGFLLLASLRQ和TLLALERKDHS完全不结合,这表明当肝素结合序列MKKTRG两侧分别为肽VDAVRTEKGFLLLASLRQ和TLLALERKDHS时,它构成了一个DCN结合位点。序列VDAVRTEKGFLLLASLRQMKKTRGTLLALERKDHS构成了TSP N端结构域中的一个细胞黏附活性位点[Clezardin等人,1997年],DCN分别抑制成纤维细胞和成骨细胞与肽VDAVRTEKGFLLLASLRQMKKTRGT和KKTRGTLLALERKDHS的附着约50%和80%。尽管成纤维细胞也附着于TSP的3型重复序列和C端结构域,但DCN仅抑制细胞与C端结构域的附着。总体而言,这些数据表明,通过空间位阻作用调节细胞对TSP N端结构域中存在的依赖KKTR的细胞黏附位点的黏附,可能解释了DCN的抗黏附特性。